To direct the Comptroller General of the United States to submit a report describing the response of certain entities to the COVID-19 pandemic with respect to the development, regulatory evaluation, and deployment of diagnostic tests.
USA116th CongressHR-6839| House
| Updated: 5/12/2020
Abigail Davis Spanberger
Democratic Representative
Virginia
Cosponsors (1)
Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
This bill requires the Government Accountability Office (GAO) to report on diagnostic tests to diagnose COVID-19 (i.e., coronavirus disease 2019) or detect the virus that causes the disease. Specifically, the report must describe the response of, among others, laboratories, diagnostic test manufacturers, and government entities with respect to the development, regulatory evaluation, and deployment of diagnostic tests. The GAO must also assess standards, guidance, clinical processes, and intergovernmental coordination related to COVID-19 testing.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Health
Blood and blood diseasesCardiovascular and respiratory healthCongressional oversightDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careGovernment studies and investigationsHealth facilities and institutionsInfectious and parasitic diseasesMedical tests and diagnostic methodsState and local government operations
To direct the Comptroller General of the United States to submit a report describing the response of certain entities to the COVID-19 pandemic with respect to the development, regulatory evaluation, and deployment of diagnostic tests.
USA116th CongressHR-6839| House
| Updated: 5/12/2020
This bill requires the Government Accountability Office (GAO) to report on diagnostic tests to diagnose COVID-19 (i.e., coronavirus disease 2019) or detect the virus that causes the disease. Specifically, the report must describe the response of, among others, laboratories, diagnostic test manufacturers, and government entities with respect to the development, regulatory evaluation, and deployment of diagnostic tests. The GAO must also assess standards, guidance, clinical processes, and intergovernmental coordination related to COVID-19 testing.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Abigail Davis Spanberger
Democratic Representative
Virginia
Cosponsors (1)
Energy and Commerce Committee
Health
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Blood and blood diseasesCardiovascular and respiratory healthCongressional oversightDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careGovernment studies and investigationsHealth facilities and institutionsInfectious and parasitic diseasesMedical tests and diagnostic methodsState and local government operations